Allenza previously spent 13 years with FMC Corporation, as senior research manager and then senior manager of technology acquisition and licensing at the company's research facility in Princeton, NJ.
Richard Brennan, Paul Allenza
GeneGo, a St. Joseph, Mich.-based provider of systems biology databases, software, and services, this week announced that Richard Brennan has been appointed director of toxicology. Brennan will lead the MetaTox Consortium, a joint industry and government effort focused on the development of systems biology tools to predict the human toxicity of new compounds.
Prior to joining GeneGo, Brennan was director of molecular and investigative toxicology at Iconix Biosciences. Before that, Brennan was an associate director of pharmacology and cell biology at Cornerstone Pharmaceuticals and a senior scientist at OSI Pharmaceuticals.
The University of Maryland this week announced the appointment of Paul Allenza as the new director of its Biotechnology Research and Education Program, an initiative dedicated to the research, education, and development of biotechnology products and processes for Maryland companies.